CN109912488B - Method for synthesizing 3-alkyl indoline by alkylation of non-activated olefin under catalysis of copper - Google Patents

Method for synthesizing 3-alkyl indoline by alkylation of non-activated olefin under catalysis of copper Download PDF

Info

Publication number
CN109912488B
CN109912488B CN201910136346.7A CN201910136346A CN109912488B CN 109912488 B CN109912488 B CN 109912488B CN 201910136346 A CN201910136346 A CN 201910136346A CN 109912488 B CN109912488 B CN 109912488B
Authority
CN
China
Prior art keywords
methyl
cyclohexylmethyl
alkyl
bromoindolin
octanone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910136346.7A
Other languages
Chinese (zh)
Other versions
CN109912488A (en
Inventor
梁德强
霍波洁
王宝玲
李维莉
马银海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kunming University
Original Assignee
Kunming University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunming University filed Critical Kunming University
Priority to CN201910136346.7A priority Critical patent/CN109912488B/en
Publication of CN109912488A publication Critical patent/CN109912488A/en
Application granted granted Critical
Publication of CN109912488B publication Critical patent/CN109912488B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention provides a method for synthesizing 3-alkyl indoline by alkylating non-activated olefin under the catalysis of copper, which uses a composite catalyst formed by copper halide and DTBP to react simple alkane with the DTBPN-allylaniline derivative generationexoThe 2-unsubstituted 3-alkyl indoline is obtained by selective alkylation/cyclization cascade reaction, and the method is simple, the substrate adaptability is wide, and the process operability is strong.

Description

Method for synthesizing 3-alkyl indoline by alkylation of non-activated olefin under catalysis of copper
Technical Field
The invention belongs to the technical field of organic synthesis, and particularly relates to a method for synthesizing 3-alkylindoline by alkylation of non-activated olefin under catalysis of copper.
Background
Alkanes are the main components of fossil fuels such as petroleum, natural gas and coal, and are first-grade products of the petrochemical industry. Therefore, the conversion of this bulk chemical into a more valuable compound is one of the core tasks of sustainable chemistry in the future. Direct C-H bond functionalization is an ideal reaction with atom and step economy, and inert alkane C-H bond direct functionalization has been a great challenge in this field due to extremely weak acidity and high dissociation energy. Indolines are very important nitrogen-containing heterocyclic compounds and have great application in the dye industry, the synthesis of perfumes and organic intermediates, the synthesis of medicines and pesticides. Due to the diverse biological activity and clinical application of compounds taking indoline as a parent nucleus structure, scientists are required to synthesize more indoline derivatives with diverse structures as drug lead molecules. The method for directly synthesizing high-value alkyl indoline from cheap simple alkane by utilizing C-H bond functionalization reaction is attractive, but the high-value compounds such as alkyl indoline obtained by the reaction of the simple alkane and non-activated alkene are rarely reported, which is probably caused by the problem of mismatch of the polarities of the reaction. Unactivated alkyl groups have weak nucleophilicity, they tend to react with electron deficient species, whereas the dehydrogenation coupling of simple alkanes with non-activated alkenes (nucleophiles) in the absence of suitable catalysts is difficult to perform.
Disclosure of Invention
In order to solve the problems in the prior art, the invention aims to provide a method for synthesizing 3-alkylindoline by alkylating non-activated olefin under the catalysis of copper, which directly uses simple alkane and N-allylaniline derivative to carry out exo selective alkylation/cyclization cascade reaction under the catalysis of copper to obtain 2-site unsubstituted 3-alkylindoline.
The purpose of the invention is realized as follows:
a method for synthesizing 3-alkyl indoline by alkylation of non-activated olefin under catalysis of copper is characterized in that the reaction route is as follows:
Figure GDA0003533842260000021
wherein:
a is C or N;
R1is hydrogen, halogen, C1-6Alkyl or phenyl;
R2is hydrogen or C1-6An alkyl group;
R3is COR4Or SO2R5
R4Is C1-17Alkyl or-O-C1-6An alkyl group;
R5is C1-6Alkyl, N-dimethyl or
Figure GDA0003533842260000022
R6Is hydrogen, halogen, hydroxy, C1-6Alkyl or-O-C1-6An alkyl group;
the catalyst comprises a catalyst 1 and a catalyst 2, wherein the catalyst 1 is selected from copper halide, and the catalyst 2 is selected from DTBP.
The term "halogen" as used herein refers to fluorine, chlorine, bromine or iodine. The term "C" as used herein1-6Alkyl "means a saturated straight or branched chain hydrocarbon group having 1 to 6 carbon atoms, e.g. methylEthyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl, isohexyl and the like, preferably methyl, ethyl, propyl, isopropyl, tert-butyl or isobutyl. The term "C" as used herein1-17Alkyl "means a saturated, straight-chain or branched-chain hydrocarbon group having from 1 to 17 carbon atoms, such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl, isohexyl, n-C7H15、n-C9H19、n-C11H23、n-C17H35. The term "-O-C" as used in the present invention1-6Alkyl "means a saturated straight or branched chain alkoxy group having 1 to 6 carbon atoms, such as methoxy, ethoxy, t-butoxy, and the like. The term "alkyl" as used herein is an alkyl group, preferably C1-17Alkyl or cycloalkyl.
The term "copper halide" used in the present invention is preferably copper chloride, copper bromide or copper iodide, more preferably copper iodide. Further, the amount of copper iodide used in the present invention is 5 to 10 mol%. The DTBP of the invention is used in an amount of 3-3.5 equivalents. The reaction temperature of the method is preferably 140-160 ℃.
Further, in the present invention, R1Selected from hydrogen, methyl, chlorine, bromine or phenyl; r2Selected from hydrogen or methyl; r3Is COR4Or SO2R5;R4Selected from methyl, ethyl, n-C7H15、n-C9H19、n-C11H23、n-C17H35t-Bu or tert-butoxy; r5Selected from methyl, ethyl, N-dimethyl; alkyl is selected from cyclopentyl, cyclohexyl, cycloheptyl.
In the compounds of formula I and formula II herein, R1Can be independently ortho-position, meta-position or para-position, can be simultaneously substituted by the ortho-position, the meta-position or/and the para-position, and can also be independently substituted; r6Can be independently ortho-position, meta-position or para-position, can be simultaneously substituted by the ortho-position, the meta-position or/and the para-position, and can also be independently substituted.
The compound of formula II of the present invention is selected from the group consisting of compounds 2a1-4e, as shown in Table 1 below.
TABLE 12 a1-4c Compounds
Figure GDA0003533842260000031
Figure GDA0003533842260000041
Figure GDA0003533842260000051
Figure GDA0003533842260000061
Advantageous effects
Without intending to be bound by any theory, it is believed that although the synthesis of high value alkylindolines by reacting simple alkanes with non-activated alkenes is very attractive, the non-activated alkyls have a weak nucleophilicity, they tend to react with electron deficient species, and the dehydrocoupling of simple alkanes with non-activated alkenes in the absence of a suitable catalyst is difficult to achieve. The present inventors have conducted experiments on alkylation/cyclization reactions of N-allylaniline derivatives with simple alkanes, and have surprisingly found that the use of a composite catalyst formed from copper halide and DTBP allows the exo-selective alkylation/cyclization cascade reaction of simple alkanes with N-allylaniline derivatives to obtain 2-unsubstituted 3-alkylindolines, and that the process is simple, substrate adaptability is broad, and process operability is strong.
Detailed Description
In order to make the objects and technical solutions of the present invention clearer, preferred embodiments of the present invention are described in detail below. It is to be noted that: the following examples are intended to illustrate the invention further and are not to be construed as limiting the scope of the invention. The invention is not limited to the embodiments described above, but rather, many modifications and variations may be made by one skilled in the art without departing from the scope of the invention.
The compound of formula I as a raw material of the present invention can be prepared by reference to literature references (literature reference 1: D.Liang, Q.Dong, P.Xu, Y.Dong, W.Li, Y.Ma, J.Org.Chem.2018,83, 11978-11986; literature reference 2: S.O' Sullivan, E.Doni, T.Tuttle, J.A.Murphy.Angew.Chem.int.Ed.2014,53, 474-478; Angew.Chem.2014,126, 484-488; literature reference 3: Z.Wu, S.Li, H.Xu.Angew.Chem.int.Ed.2018,57, 14070-14074; Angew.Chem.2018,130, 14266-14270.; 4: CN 201811634880.2).
Example 1
Alkylation of N-allylaniline derivatives to alkyl indolines (as an example for the synthesis of 2a 1) is carried out as follows:
Figure GDA0003533842260000062
the method comprises the following operation steps: to a Schlenk tube equipped with a magnetic stirrer were added N-allylamine derivative 1a1(57mg, 0.3mmol), DTBP (154mg, 1.05mmol), CuI (3mg, 0.015mmol), and cyclohexane (3.0mL) in that order. The mixture was stirred at 140 ℃ under sealed heating for 6h, then saturated Na was added2S2O3Aqueous solution (2mL) and water (10.0 mL). The mixture was extracted 3 more times with dichloromethane (10.0mL) and the organic phases were combined. The organic solvent was evaporated using a rotary evaporator and the resulting residue was subjected to column chromatography using 300-400 mesh silica gel as the stationary phase and petroleum ether and ethyl acetate as the eluent to give the 3-alkylindoline product 2a 1.
The effect of the catalyst and temperature on the reaction was examined with reference to example 1, and the details are shown in Table 2.
Table 2 shows the influence of the catalyst and temperature on the reaction[a]
Figure GDA0003533842260000071
[a]Reaction conditions are as follows: 1a1(0.3mmol), cyclohexane (3.0mL), 140 deg.C, 6 h.
[b]5.0-6.0mol/L decane solution.
The inventors began the present study on the alkylation/cyclization reaction of N- (2-methylallyl) acetanilide 1a1 (Table 2). Satisfactorily, 1a1 was reacted with cyclohexane at 140 ℃ in the presence of 10 mol% CuI and 3.5 equivalents of di-tert-butyl peroxide (DTBP) to give 3- (cyclohexylmethyl) indoline 2a1 (sequence No. 1) in 81% yield. Control experiments showed that the yield was low without the copper catalyst (number 2). CuBr (No. 3) and CuCl (No. 4) are also usable catalysts, and Cu (OAc)2(No. 5) MnCl2(No. 8) CoCl2(No. 9) or tetrabutylammonium iodide (TBAI, No. 10) showed almost no advantageous effect. Using FeCl3(number 6) or AgNO3(No. 7), the yield was lower than that of the cuprous-catalyzed reaction. Next, the inventors tested a series of oxidants against DTBP. The yield decreased to some extent when dicumyl peroxide (DCP, No. 11) or anhydrous tert-butyl hydroperoxide (TBHP, No. 12) was used, while dibenzoyl peroxide (BPO, No. 13), tert-butyl perbenzoate (TBPB, No. 14), m-chloroperoxybenzoic acid (mCPBA, No. 15), K2S2O8Both (No. 16) and Oxone (No. 17) are ineffective oxidants for this reaction. Under otherwise optimal conditions, when the reaction is carried out at 120 ℃ the yield of the 2-position unsubstituted 3-alkylindoline 2a1 is only 11% (No. 18), while a decrease in the amount of DTBP also decreases the yield (No. 19). Finally, the inventors found that using 5% CuI was sufficient to obtain a satisfactory yield (No. 20).
After obtaining the optimal reaction conditions, the inventors further investigated the applicable range of the substrate (see table 3 below for details). N-allylated acetanilides bearing bromine or chlorine atoms in the para-position of the N-aryl group can be reacted smoothly with cyclohexane and yield in high yields of the corresponding 3-alkylindolines 2a3,4, whereas methyl and phenyl substituents are unfavorable, 5-methyl or 5-phenylindolines 2a2,5 being produced only in moderate yields. It is noted that 3-alkyl-2, 3-dihydropyrrolo [3,2-c ] pyridines 2b can also be synthesized from the corresponding allylated 4-aminopyridines. The reaction involving propionyl-protected N-allylaniline gives indolines 2c1,2 in 61-71% yield, which are sensitive to steric effects, and the yields of 3-alkylindolines 2d1,2 and 2e1,2 protected by long chain acyl groups (such as octanoyl, dodecanoyl and stearoyl) are relatively reduced, whereas the corresponding indolines 2e3 can only be obtained in very low yields when using more sterically hindered pivaloyl substrates. The substrate having a t-butoxy substituent on the nitrogen atom was reacted with the solvent cyclohexane to produce the product 2f in 62% yield. This alkylation/cyclization cascade can also be extended to N-allylated sulfonamide substrates. Overall, the yield of N-methanesulfonyl or N-ethanesulfonylindoline, 2g, h, was higher than the yield of o-toluenesulfonyl or dimethylsulfamoyl product, 2i, j. Allylated N-o-toluenesulfonyl para-chloroaniline is a challenging substrate and its reaction needs to be carried out at 160 ℃. Allylated 3, 5-dichloroaniline is also a highly reactive substrate and corresponds to 4, 6-dichloroindoline 2k produced in 70% yield. Other alkane solvents may also participate in the reaction to produce the corresponding cyclopentylmethyl, cycloheptylmethyl, or cyclooctylmethylindoline 2l-n in moderate to high yields.
TABLE 3 Synthesis of 3-alkylindolines from N-allylaniline
Figure GDA0003533842260000091
[a]Reaction conditions are as follows: 1(0.3mmol), DTBP (1.05mmol), CuI (0.015mmol), alkane solvent (3.0mL), 140 ℃,6 h.
[b]The reaction was carried out at 160 ℃.
The 6-endo-trig cyclization process may also occur in the present reaction according to the Bowden temperature rule. In the early days, the inventors all used N- (2-methallyl) substrates and after the above reactions all achieved exo selectivity, the inventors attempted to extend the reaction to simple N-allylaniline derivatives. It is surprising that the reaction without a methyl-branched substrate also exhibits a high exo selectivity, although the corresponding 3-monosubstituted indolines 4a-c are produced in only moderate yields, as specified below.
Figure GDA0003533842260000101
Alkylation/cyclization of unbranched N-allylic amides
In conclusion, the inventor develops a copper-catalyzed exo-selective N-allylaniline alkylation/cyclization cascade reaction, the reaction directly synthesizes 2-position unsubstituted 3-alkyl indoline by using non-activated olefin and simple alkane, and the reaction has simple operation and wide substrate range. This is a simple alkane with an inactive alkene C (sp)3) Rare examples of-H bond functionalization reactions.
Nuclear magnetic data of target product
2a1, 1- (3-methyl-3- (cyclohexylmethyl) indolin-1-yl) -1-ethanone, an inseparable rotamer mixture of 2:9 (derived from hindered rotation of the N- (CO) bond in the amide group), pale yellow oil.1H NMR(400MHz,CDCl3)δ=0.83-1.65(m,16H),2.22(s,3H),3.70(d,J=10.2Hz,1H),3.90(d,J=10.2Hz,1H),7.03(ddd,J=0.8,7.4,7.4Hz,1H),7.10(dd,J=0.8,7.4Hz,1H),7.17-7.21(m,1H),8.18(d,J=8.1Hz,1H);13C NMR(100MHz,CDCl3)δ=168.66,141.82,140.09,127.70,123.69,122.36,116.91,61.91,48.60,43.69,35.48,34.73,34.62,27.84,26.37,26.30,26.13,24.33;HRMS(ESI-TOF)Calcd for C18H26NO+([M+H]+)272.2009.Found 272.2010.
2a2, 1- (3, 5-dimethyl-3- (cyclohexylmethyl) indolin-1-yl) -1-ethanone, a non-separable rotameric mixture of 1:4, a light brown oil.1H NMR(400MHz,CDCl3)δ=0.83-1.65(m,16H),2.21(s,3H),2.31(s,3H),3.68(d,J=10.2Hz,1H),3.89(d,J=10.2Hz,1H),6.89(s,1H),6.99(d,J=7.4Hz,1H),8.05(d,J=8.2Hz,1H);13C NMR(100MHz,CDCl3)δ=168.31,140.31,139.50,133.25,128.17,122.92,116.62,62.04,48.56,43.64,35.48,34.72,34.65,27.71,26.37,26.31,26.14,24.22,21.17;HRMS(ESI-TOF)Calcd for C19H28NO+([M+H]+)286.2165.Found 286.2176.
2a3, 1- (3-methyl-3- (cyclohexylmethyl) -5-bromoindolin-1-yl) 1-ethanone, 1:9 rotamer mixture, yellowish oil.1H NMR(400MHz,CDCl3)δ=0.84-1.67(m,16H),2.21(s,3H),3.71(d,J=10.2Hz,1H),3.91(d,J=10.2Hz,1H),7.19(d,J=1.5Hz,1H),7.29(dd,J=1.6,8.6Hz,1H),8.07(d,J=8.6Hz,1H);13C NMR(100MHz,CDCl3)δ=168.72,142.56,140.90,130.56,125.59,118.37,116.09,61.87,48.43,43.79,35.39,34.67,34.62,27.79,26.32,26.27,26.07,24.22;HRMS(ESI-TOF)Calcd for C18H25BrNO+([M+H]+)350.1114.Found 350.1112.
2a4, 1- (3-methyl-3- (cyclohexylmethyl) -5-chloroindolin-1-yl) -1-ethanone, 1:9 rotameric mixture, light yellow oil.1H NMR(400MHz,CDCl3)δ=0.84-1.67(m,16H),2.21(s,3H),3.72(d,J=10.2Hz,1H),3.92(d,J=10.2Hz,1H),7.04(d,J=2.0Hz,1H),7.15(dd,J=2.2,8.6Hz,1H),8.12(d,J=8.6Hz,1H);13C NMR(100MHz,CDCl3)δ=168.66,142.16,140.43,128.54,127.63,122.68,117.89,61.92,48.42,43.79,35.39,34.67,34.61,27.81,26.32,26.26,26.07,24.18;HRMS(ESI-TOF)Calcd for C18H25ClNO+([M+H]+)306.1619.Found 306.1606.
2a5, 1- (3-methyl-3- (cyclohexylmethyl) -5-phenylindolin-1-yl) -1-ethanone, 1:6 rotameric mixture, light yellow oil.1H NMR(400MHz,CDCl3)δ=0.83-1.69(m,16H),2.25(s,3H),3.75(d,J=10.2Hz,1H),3.96(d,J=10.2Hz,1H),7.30-7.33(m,2H),7.40-7.45(m,3H),7.57(d,J=7.4Hz,2H),8.24(d,J=8.4Hz,1H);13C NMR(100MHz,CDCl3)δ=168.62,141.27,141.15,140.79,136.85,128.73,126.90,126.73,121.06,117.04,62.16,48.61,43.78,35.49,34.76,34.67,27.87,26.37,26.30,26.11,24.28;HRMS(ESI-TOF)Calcd for C24H30NO+([M+H]+)348.2322.Found 348.2325.
2b, 1- (3-methyl-3- (cyclohexylmethyl) -2, 3-dihydro-1H-pyrrolo [3, 2-c)]Pyridin-1-yl) -1-ethanone, a 2:15 rotamer mixture, a light brown oil.1H NMR(400MHz,CDCl3)δ=0.83-1.68(m,16H),2.25(s,3H),3.73(d,J=10.1Hz,1H),3.93(d,J=10.0Hz,1H),8.00(d,J=5.2Hz,1H),8.32(s,1H),8.40(d,J=5.5Hz,1H);13C NMR(100MHz,CDCl3)δ=169.76,149.72,148.39,144.44,135.22,111.32,62.08,48.51,43.12,35.36,34.72,34.66,28.08,26.31,26.25,26.03,24.33;HRMS(ESI-TOF)Calcd for C17H25N2O+([M+H]+)273.1961.Found 273.1976.
2c1, 1- (3, 5-dimethyl-3- (cyclohexylmethyl) indolin-1-yl) -1-propanone, rotameric mixture of 2:11, yellowish oil.1H NMR(400MHz,CDCl3)δ=0.83-1.66(m,19H),2.31(s,3H),2.43(q,J=7.4Hz,2H),3.67(d,J=10.2Hz,1H),3.88(d,J=10.2Hz,1H),6.89(s,1H),6.99(d,J=8.0Hz,1H),8.09(d,J=8.2Hz,1H);13C NMR(100MHz,CDCl3)δ=171.67,140.19,139.73,133.08,128.19,122.89,116.57,61.05,48.56,43.64,35.50,34.73,34.64,29.16,27.70,26.37,26.32,26.14,21.16,8.81;HRMS(ESI-TOF)Calcd for C20H30NO+([M+H]+)300.2322.Found 300.2326.
2c2, 1- (3-methyl-3- (cyclohexylmethyl) -5-bromoindolin-1-yl) -1-propanone, as a yellowish solid mp 100-.1H NMR(400MHz,CDCl3)δ=0.84-1.64(m,19H),2.43(q,J=7.3Hz,2H),3.69(d,J=10.2Hz,1H),3.90(d,J=10.2Hz,1H),7.19(d,J=1.5Hz,1H),7.29(dd,J=2.0,8.6Hz,1H),8.11(d,J=8.6Hz,1H);13C NMR(100MHz,CDCl3)δ=172.08,142.44,141.14,130.57,125.56,118.30,115.91,60.90,48.44,43.79,35.41,34.68,34.62,29.20,27.79,26.33,26.27,26.07,8.68;HRMS(ESI-TOF)Calcd for C19H27BrNO+([M+H]+)364.1271.Found 364.1273.
2d1, 1- (3, 5-dimethyl-3- (cyclohexylmethyl) indolin-1-yl) -1-octanone, 1:6 rotamer mixture, yellowish oil.1H NMR(400MHz,CDCl3)δ=0.83-1.64(m,27H),1.69-1.77(m,2H),2.31(s,3H),2.39(t,J=7.7Hz,2H),3.68(d,J=10.2Hz,1H),3.89(d,J=10.2Hz,1H),6.89(s,1H),6.99(d,J=8.2Hz,1H),8.09(d,J=8.2Hz,1H);13C NMR(100MHz,CDCl3)δ=171.15,140.22,139.75,133.08,128.17,122.87,116.66,61.22,48.59,43.60,36.01,35.51,34.74,34.64,31.75,29.42,29.19,27.68,26.38,26.33,26.15,24.74,22.66,21.16,14.10;HRMS(ESI-TOF)Calcd for C25H40NO+([M+H]+)370.3104.Found 370.3104.
2d2, 1- (3-methyl-3- (cyclohexylmethyl) -5-bromoindolin-1-yl) -1-octanone, as a yellowish solid mp 84-85 ℃.1H NMR(400MHz,CDCl3)δ=0.84-1.76(m,29H),2.39(t,J=7.6Hz,2H),3.70(d,J=10.2Hz,1H),3.91(d,J=10.2Hz,1H),7.18(d,J=1.6Hz,1H),7.29(dd,J=2.0,8.6Hz,1H),8.10(d,J=8.6Hz,1H);13C NMR(100MHz,CDCl3)δ=171.56,142.47,141.15,130.54,125.54,118.40,115.92,61.06,48.48,43.75,35.99,35.42,34.69,34.61,31.72,29.35,29.17,27.78,26.33,26.28,26.07,24.60,22.65,14.10;HRMS(ESI-TOF)Calcd for C24H37BrNO+([M+H]+)434.2053.Found 434.2049.
2e1, 1- (3-methyl-3- (cyclohexylmethyl) -5-bromoindolin-1-yl) -1-decadione, yellowish oil.1H NMR(400MHz,CDCl3)δ=0.83-1.76(m,37H),2.39(t,J=7.6Hz,2H),3.70(d,J=10.2Hz,1H),3.91(d,J=10.2Hz,1H),7.18(d,J=1.6Hz,1H),7.29(dd,J=2.0,8.6Hz,1H),8.10(d,J=8.6Hz,1H);13C NMR(100MHz,CDCl3)δ=171.58,142.46,141.15,130.56,125.54,118.40,115.93,61.07,48.48,43.75,36.00,35.43,34.69,34.61,31.92,29.65,29.63,29.53,29.51,29.40,29.35,27.78,26.33,26.28,26.07,24.60,22.70,14.13;HRMS(ESI-TOF)Calcd for C28H45BrNO+([M+H]+)490.2679.Found 490.2680.
2e2, 1- (3-methyl-3- (cyclohexylmethyl) -5-bromoindolin-1-yl) -1-octadecanone, yellowish oil.1H NMR(400MHz,CDCl3)δ=0.81-1.76(m,49H),2.39(t,J=7.6Hz,2H),3.70(d,J=10.2Hz,1H),3.91(d,J=10.2Hz,1H),7.18(d,J=1.7Hz,1H),7.29(dd,J=2.0,8.6Hz,1H),8.10(d,J=8.6Hz,1H);13C NMR(100MHz,CDCl3)δ=171.58,142.46,141.15,130.56,125.54,118.40,115.93,61.07,48.48,43.75,36.00,35.43,34.69,34.61,31.94,29.71,29.69,29.67,29.65,29.53,29.51,29.40,29.38,27.78,26.33,26.28,26.07,24.60,22.71,14.14;HRMS(ESI-TOF)Calcd for C34H57BrNO+([M+H]+)574.3618.Found 574.3619.
2e3, 2, 2-dimethyl-1- (3-methyl-3- (cyclohexylmethyl) -5-bromoindolin-1-yl) -1-propanone, light yellow oil.1H NMR(400MHz,CDCl3)δ=0.84-1.68(m,25H),3.89(d,J=10.1Hz,1H),4.08(d,J=10.1Hz,1H),7.19(d,J=2.1Hz,1H),7.29(dd,J=2.1,8.7Hz,1H),8.10(d,J=8.7Hz,1H);13C NMR(100MHz,CDCl3)δ=176.48,142.73,142.15,130.34,125.21,119.84,116.14,62.26,47.66,44.41,40.21,35.57,34.66,34.53,27.64,26.34,26.26,26.07;HRMS(ESI-TOF)Calcd for C21H31BrNO+([M+H]+)392.1584.Found 392.1582.
Tert-butyl 2f, 3-methyl-3- (cyclohexylmethyl) -5-chloroindoline-1-carboxylate, rotamer mixture of 2:3, yellowish solid mp 101-.1H NMR(400MHz,CDCl3)δ=0.82-1.66(m,25H),3.64(brs,1H,unexchangeable),3.84(brs,1H,unexchangeable),7.01(d,J=2.2Hz,1H),7.10(d,J=8.4Hz,1H),7.32(brs,0.38H(1H minor),unexchangeable),7.76(brs,0.57H(1H major),unexchangeable);13C NMR(100MHz,CDCl3)δ=151.42,141.89(br,major or minor),140.80(bs,major and minor),139.56(br,major or minor),126.36,126.13,121.77(bs,major and minor),114.58,80.54(br,minor),79.72(br,major),59.55(bs,major and minor),47.46,42.06(bs,major),41.55(bs,minor),34.37,33.62,33.52,27.43,26.80,25.35,25.28,25.11;HRMS(ESI-TOF)Calcd for C21H31ClNO2 +([M+H]+)364.2038.Found 364.2038.
2g1, 3-methyl-3- (cyclohexylmethyl) -1- (methylsulfonyl) -5-bromoindoline, a light brown oil.1H NMR(400MHz,CDCl3)δ=0.86-1.68(m,16H),2.89(s,3H),3.66(d,J=10.1Hz,1H),3.83(d,J=10.1Hz,1H),7.22(d,J=1.8Hz,1H),7.26(d,J=8.7Hz,1H),7.29-7.32(m,1H);13C NMR(100MHz,CDCl3)δ=142.62,139.96,130.96,126.52,116.22,114.68,62.64,47.89,43.85,35.42,34.62,34.61,34.59,27.04,26.33,26.28,26.05;HRMS(ESI-TOF)Calcd for C17H25BrNO2S+([M+H]+)386.0784.Found 386.0785.
2g2, 3-methyl-3- (cyclohexylmethyl) -5-phenyl-1- (methylsulfonyl) indoline, a slightly brown oil.1H NMR(400MHz,CDCl3)δ=0.83-1.72(m,16H),2.93(s,3H),3.70(d,J=10.0Hz,1H),3.87(d,J=10.0Hz,1H),7.31-7.35(m,2H),7.41-7.45(m,4H),7.53-7.55(m,2H);13C NMR(100MHz,CDCl3)δ=140.87,140.79,140.21,137.02,128.82,127.15,127.12,126.90,122.03,113.34,62.88,48.07,43.83,35.52,34.73,34.66,34.54,27.15,26.40,26.33,26.10;HRMS(ESI-TOF)Calcd for C23H30NO2S+([M+H]+)384.1992.Found 384.2003.
2h1, 3-methyl-3- (cyclohexylmethyl) -1- (ethylsulfonyl) -5-bromoindoline, brown oil.1H NMR(400MHz,CDCl3)δ=0.85-1.65(m,19H),3.11(q,J=7.4Hz,2H),3.71(d,J=10.1Hz,1H),3.89(d,J=10.1Hz,1H),7.20(d,J=1.6Hz,1H),7.22(d,J=8.7Hz,1H),7.27(dd,J=1.8,8.5Hz,1H);13C NMR(100MHz,CDCl3)δ=142.34,140.24,130.79,126.45,115.64,114.50,62.59,47.89,44.23,43.89,35.43,34.60,27.14,26.34,26.28,26.05,7.81;HRMS(ESI-TOF)Calcd for C18H27BrNO2S+([M+H]+)400.0940.Found 400.0938.
2h2, 3-methyl-3- (cyclohexylmethyl) -1- (ethylsulfonyl) -5-chloroindoline, brown oil.1H NMR(400MHz,CDCl3)δ=0.85-1.68(m,19H),3.11(q,J=7.4Hz,2H),3.72(d,J=10.1Hz,1H),3.90(d,J=10.1Hz,1H),7.06(d,J=2.1Hz,1H),7.12(dd,J=2.2,8.6Hz,1H),7.27(d,J=8.6Hz,1H);13C NMR(100MHz,CDCl3)δ=141.95,139.72,128.27,127.89,123.56,114.01,62.64,47.88,44.19,43.90,35.44,34.61,34.58,27.15,26.34,26.28,26.05,7.80;HRMS(ESI-TOF)Calcd for C18H27ClNO2S+([M+H]+)356.1446.Found 356.1433.
2h3, 3-methyl-3- (cyclohexylmethyl) -5-phenyl-1- (ethylsulfonyl) indoline, a slightly brown oil.1H NMR(400MHz,CDCl3)δ=0.83-1.71(m,19H),3.16(q,J=7.4Hz,2H),3.77(d,J=10.0Hz,1H),3.94(d,J=10.0Hz,1H),7.31-7.34(m,2H),7.40-7.44(m,4H),7.53-7.55(m,2H);13C NMR(100MHz,CDCl3)δ=140.88,140.61,140.46,136.52,128.80,127.03,126.99,126.87,122.00,113.15,62.83,48.07,44.09,43.87,35.53,34.71,34.67,27.26,26.40,26.34,26.11,7.86;HRMS(ESI-TOF)Calcd for C24H32NO2S+([M+H]+)398.2148.Found 398.2145.
2i, 3-methyl-3- (cyclohexylmethyl) -1- (o-tolylsulfonyl) -5-chloroindoline, a slightly brown oil.1H NMR(400MHz,CDCl3)δ=0.73-0.93(m,2H),1.01-1.29(m,8H),1.34-1.63(m,6H),2.59(s,3H),3.64(d,J=10.2Hz,1H),3.81(d,J=10.2Hz,1H),7.00(d,J=2.1Hz,1H),7.09(dd,J=2.2,8.6Hz,1H),7.29-7.32(m,2H),7.34(d,J=8.6Hz,1H),7.46(ddd,J=1.3,7.5,7.5Hz,1H),7.93(dd,J=1.1,8.0Hz,1H);13C NMR(100MHz,CDCl3)δ=142.00,140.14,138.12,137.16,133.12,132.99,129.40,128.35,127.72,126.30,123.36,115.07,61.66,47.78,43.90,35.34,34.46,34.42,26.97,26.26,26.21,26.03,20.94;HRMS(ESI-TOF)Calcd for C23H29ClNO2S+([M+H]+)418.1602.Found 418.1617.
2j1, N, 3-trimethyl-3- (cyclohexylmethyl) -5-bromoindoline-1-sulfonamide, dark brown oil.1H NMR(400MHz,CDCl3)δ=0.84-1.68(m,16H),2.89(s,6H),3.67(d,J=9.8Hz,1H),3.86(d,J=9.9Hz,1H),7.17(s,1H),7.18(d,J=8.6Hz,1H),7.25(dd,J=2.0,8.7Hz,1H);13C NMR(100MHz,CDCl3)δ=141.94,141.01,130.60,126.07,115.12,114.83,62.91,47.95,43.86,38.28,35.48,34.60,34.57,27.14,26.36,26.31,26.07;HRMS(ESI-TOF)Calcd for C18H28BrN2O2S+([M+H]+)415.1049.Found 415.1044.
2j2, N, N, 3-trimethyl-3- (cyclohexylmethyl) -5-phenylindoline-1-sulfonylAmine, slightly brown oil.1H NMR(400MHz,CDCl3)δ=0.83-1.69(m,16H),2.92(s,6H),3.73(d,J=9.8Hz,1H),3.92(d,J=9.9Hz,1H),7.29-7.33(m,2H),7.36(d,J=8.2Hz,1H),7.38(d,J=1.8Hz,1H),7.40-7.45(m,2H),7.53-7.55(m,2H);13C NMR(100MHz,CDCl3)δ=141.28,141.06,140.19,136.01,128.76,126.88,126.86,126.81,121.66,113.43,63.16,48.11,43.83,38.32,35.58,34.71,34.64,27.24,26.42,26.36,26.13;HRMS(ESI-TOF)Calcd for C24H33N2O2S+([M+H]+)413.2257.Found 413.2259.
2k, 1- (3-methyl-3- (cyclohexylmethyl) -4, 6-dichloroindolin-1-yl) -1-octanone, as a yellowish oil.1H NMR(400MHz,CDCl3)δ=0.84-1.75(m,28H),1.95(dd,J=5.8,15.5Hz,1H),2.38(d,J=7.4Hz,2H),3.70(d,J=10.4Hz,1H),3.99(d,J=10.4Hz,1H),6.97(d,J=1.9Hz,1H),8.29(s,1H);13C NMR(100MHz,CDCl3)δ=171.80,144.98,134.05,133.30,130.51,124.68,115.94,61.65,45.85,44.98,36.12,35.19,34.83,34.20,31.71,29.29,29.16,26.95,26.32,26.21,26.10,24.48,22.64,14.09;HRMS(ESI-TOF)Calcd for C24H36Cl2NO+([M+H]+)424.2168.Found 424.2164.
2l1, 1- (3-methyl-3- (cyclopentylmethyl) -5-bromoindolin-1-yl) -1-octanone, as a yellowish oil.1H NMR(400MHz,CDCl3)δ=0.87-1.81(m,27H),2.39(t,J=7.6Hz,2H),3.69(d,J=10.2Hz,1H),3.95(d,J=10.2Hz,1H),7.18(d,J=1.9Hz,1H),7.29(dd,J=2.1,8.6Hz,1H),8.10(d,J=8.6Hz,1H);13C NMR(100MHz,CDCl3)δ=171.53,142.14,141.40,130.57,125.64,118.38,115.92,60.87,47.70,43.98,36.99,35.98,34.70,34.18,31.73,29.35,29.16,27.84,25.13,24.74,24.55,22.64,14.10;HRMS(ESI-TOF)Calcd for C23H35BrNO+([M+H]+)420.1897.Found 420.1898.
2l2, 2, 2-dimethyl-1- (3-methyl-3- (cyclopentylmethyl) -5-bromoindolin-1-yl) -1-propanone, brown oil.1H NMR(400MHz,CDCl3)δ=0.92-1.83(m,23H),3.87(d,J=10.1Hz,1H),4.11(d,J=10.1Hz,1H),7.19(d,J=2.1Hz,1H),7.29(dd,J=2.1,8.7Hz,1H),8.10(d,J=8.7Hz,1H);13C NMR(100MHz,CDCl3)δ=176.50,142.85,142.02,130.37,125.31,119.87,116.14,62.25,46.51,44.68,40.20,36.94,34.88,34.17,27.64,26.15,25.31,24.73;HRMS(ESI-TOF)Calcd for C20H29BrNO+([M+H]+)378.1427.Found 378.1428.
2m, 1- (3-methyl-3- (cycloheptylmethyl) -5-bromoindolin-1-yl) -1-octanone, as a yellowish oil.1H NMR(400MHz,CDCl3)δ=0.89(t,J=7.0Hz,3H),1.09-1.62(m,26H),1.72(tt,J=7.3,7.3Hz,2H),2.39(t,J=7.6Hz,2H),3.69(d,J=10.2Hz,1H),3.91(d,J=10.2Hz,1H),7.19(d,J=1.9Hz,1H),7.29(dd,J=2.1,8.6Hz,1H),8.10(d,J=8.6Hz,1H);13C NMR(100MHz,CDCl3)δ=171.52,142.25,141.24,130.55,125.58,118.41,115.91,61.03,49.19,44.03,36.90,36.32,36.10,35.99,31.72,29.36,29.16,28.46,28.20,27.30,26.12,26.07,24.61,22.64,14.10;HRMS(ESI-TOF)Calcd for C25H39BrNO+([M+H]+)448.2210.Found 448.2208.
2n, 1- (3-methyl-3- (cyclooctylmethyl) -5-bromoindolin-1-yl) -1-octanone, as a yellowish oil.1H NMR(400MHz,CDCl3)δ=0.89(t,J=7.0Hz,3H),1.14-1.60(m,28H),1.72(tt,J=7.3,7.3Hz,2H),2.39(t,J=7.6Hz,2H),3.69(d,J=10.2Hz,1H),3.92(d,J=10.2Hz,1H),7.19(d,J=1.9Hz,1H),7.29(dd,J=2.1,8.6Hz,1H),8.11(d,J=8.6Hz,1H);13C NMR(100MHz,CDCl3)δ=171.50,142.17,141.30,130.55,125.63,118.43,115.91,60.96,49.22,44.02,36.00,34.42,33.86,33.62,31.72,29.36,29.16,27.42,27.24,27.21,26.26,25.15,24.96,24.61,22.65,14.10;HRMS(ESI-TOF)Calcd for C26H41BrNO+([M+H]+)462.2366.Found 462.2378.
4a, 1- (3- (cyclohexylmethyl) indolin-1-yl) -1-octanone, 1:8 rotamer mixture, light yellow oil.1H NMR(400MHz,CDCl3)δ=0.87-1.84(m,26H),2.42(t,J=7.6Hz,2H),3.43-3.50(m,1H),3.64(dd,J=6.2,10.1Hz,1H),4.14(dd,J=9.7,9.7Hz,1H),7.01(dd,J=7.4,7.4Hz,1H),7.13(d,J=7.3Hz,1H),7.19(dd,J=7.7,7.7Hz,1H),8.23(d,J=8.1Hz,1H);13C NMR(100MHz,CDCl3)δ=171.50,142.78,135.67,127.70,123.66,123.43,116.97,54.77,43.71,37.36,36.04,35.55,34.13,32.72,31.75,29.40,29.19,26.54,26.31,26.22,24.63,22.66,14.11;HRMS(ESI-TOF)Calcd for C23H36NO+([M+H]+)342.2791.Found 342.2778.
4b, 1- (5-methyl-3- (cyclohexylmethyl) indolin-1-yl) -1-octanone, 1:6 rotamer mixture, light brown oil.1H NMR(400MHz,CDCl3)δ=0.87-1.85(m,26H),2.31(s,3H),2.40(t,J=7.7Hz,2H),3.39-3.46(m,1H),3.62(dd,J=6.2,10.2Hz,1H),4.13(dd,J=9.7,9.7Hz,1H),6.94(s,1H),6.99(d,J=8.0Hz,1H),8.10(d,J=8.2Hz,1H);13C NMR(100MHz,CDCl3)δ=171.15,140.48,135.80,132.99,128.13,124.26,116.67,54.86,43.70,37.34,35.93,35.61,34.21,32.65,31.76,29.41,29.20,26.55,26.32,26.21,24.66,22.66,21.08,14.11;HRMS(ESI-TOF)Calcd for C24H38NO+([M+H]+)356.2948.Found 356.2951.
4c, 1- (3- (cyclohexylmethyl) -5-bromoindolin-1-yl) -1-octanone, yellowish semi-solid.1H NMR(400MHz,CDCl3)δ=0.89-1.84(m,26H),2.41(t,J=7.6Hz,2H),3.42-3.49(m,1H),3.64(dd,J=6.4,10.2Hz,1H),4.15(dd,J=9.8,9.8Hz,1H),7.23(s,1H),7.29(ddd,J=0.5,2.0,8.6Hz,1H),8.10(d,J=8.6Hz,1H);13C NMR(100MHz,CDCl3)δ=171.58,141.90,138.05,130.52,126.77,118.30,115.81,54.76,43.50,37.23,35.94,35.49,34.15,32.55,31.74,29.36,29.18,26.47,26.26,26.14,24.51,22.66,14.12;HRMS(ESI-TOF)Calcd for C23H35BrNO+([M+H]+)420.1897.Found 420.1898.

Claims (8)

1. A method for synthesizing 3-alkyl indoline by alkylation of non-activated olefin under catalysis of copper is characterized in that the reaction route is as follows:
Figure FDA0003533842250000011
wherein:
a is C or N;
R1is hydrogen, halogen, C1-6Alkyl or phenyl;
R2is hydrogen or C1-6An alkyl group;
R3is COR4Or SO2R5
R4Is C1-17Alkyl or-O-C1-6An alkyl group;
R5is C1-6Alkyl, N-dimethyl or
Figure FDA0003533842250000012
R6Is hydrogen, halogen, hydroxy, C1-6Alkyl or-O-C1-6An alkyl group;
the catalyst comprises a catalyst 1 and a catalyst 2, wherein the catalyst 1 is selected from copper halide, and the catalyst 2 is selected from DTBP; the copper halide is selected from CuBr, CuCl or CuI; the reaction temperature is 140-160 ℃.
2. The method of claim 1, wherein: the copper halide is selected from copper iodide.
3. The method of claim 2, wherein: the dosage of the copper iodide is 5-10 mol%.
4. The method of claim 1, wherein: the amount of the DTBP is 3-3.5 equivalents.
5. The method of any one of claims 1-4, wherein: the halogen refers to fluorine, chlorine, bromine or iodine; said C is1-6Alkyl means a saturated straight or branched chain hydrocarbon group having 1 to 6 carbon atoms; said C is1-17Alkyl means a saturated straight or branched chain hydrocarbon group having 1 to 17 carbon atoms; said-O-C1-6Alkyl means a saturated straight or branched chain alkoxy group having 1 to 6 carbon atoms.
6. The method of any one of claims 1-4, wherein: said C is1-6The alkyl group is selected from methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl or isohexyl; said C is1-17The alkyl group is selected from methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl, isohexyl, n-C7H15、n-C9H19、n-C11H23Or n-C17H35(ii) a said-O-C1-6The alkyl group is selected from methoxy, ethoxy or tert-butoxy.
7. The method of any one of claims 1-4, wherein: r1Selected from hydrogen, methyl, chlorine, bromine or phenyl; r2Selected from hydrogen or methyl; r3Is COR4Or SO2R5;R4Selected from methyl, ethyl, n-C7H15、n-C9H19、n-C11H23、n-C17H35t-Bu or tert-butoxy; r5Selected from methyl, ethyl, N-dimethyl; alkyl is selected from cyclopentyl, cyclohexyl, cycloheptyl.
8. The method of any one of claims 1-4, wherein: the compound of formula II is selected from
1- (3-methyl-3- (cyclohexylmethyl) indolin-1-yl) -1-ethanone;
1- (3, 5-dimethyl-3- (cyclohexylmethyl) indolin-1-yl) -1-ethanone;
1- (3-methyl-3- (cyclohexylmethyl) -5-bromoindolin-1-yl) -1-ethanone;
1- (3-methyl-3- (cyclohexylmethyl) -5-chloroindolin-1-yl) -1-ethanone;
1- (3-methyl-3- (cyclohexylmethyl) -5-phenylindolin-1-yl) -1-ethanone;
1- (3-methyl-3- (cyclohexylmethyl) -2, 3-dihydro-1H-pyrrolo [3,2-c ] pyridin-1-yl) -1-ethanone;
1- (3, 5-dimethyl-3- (cyclohexylmethyl) indolin-1-yl) -1-propanone;
1- (3-methyl-3- (cyclohexylmethyl) -5-bromoindolin-1-yl) -1-propanone;
1- (3, 5-dimethyl-3- (cyclohexylmethyl) indolin-1-yl) -1-octanone;
1- (3-methyl-3- (cyclohexylmethyl) -5-bromoindolin-1-yl) -1-octanone;
1- (3-methyl-3- (cyclohexylmethyl) -5-bromoindolin-1-yl) -1-decadione;
1- (3-methyl-3- (cyclohexylmethyl) -5-bromoindolin-1-yl) -1-octadecanone;
2, 2-dimethyl-1- (3-methyl-3- (cyclohexylmethyl) -5-bromoindolin-1-yl) -1-propanone;
3-methyl-3- (cyclohexylmethyl) -5-chloroindoline-1-carboxylic acid tert-butyl ester;
3-methyl-3- (cyclohexylmethyl) -1- (methylsulfonyl) -5-bromoindoline;
3-methyl-3- (cyclohexylmethyl) -5-phenyl-1- (methylsulfonyl) indoline;
3-methyl-3- (cyclohexylmethyl) -1- (ethylsulfonyl) -5-bromoindoline;
3-methyl-3- (cyclohexylmethyl) -1- (ethylsulfonyl) -5-chloroindoline;
3-methyl-3- (cyclohexylmethyl) -5-phenyl-1- (ethylsulfonyl) indoline;
3-methyl-3- (cyclohexylmethyl) -1- (o-tolylsulfonyl) -5-chloroindoline;
n, 3-trimethyl-3- (cyclohexylmethyl) -5-bromoindoline-1-sulfonamide;
n, 3-trimethyl-3- (cyclohexylmethyl) -5-phenylindoline-1-sulfonamide;
1- (3-methyl-3- (cyclohexylmethyl) -4, 6-dichloroindolin-1-yl) -1-octanone;
1- (3-methyl-3- (cyclopentylmethyl) -5-bromoindolin-1-yl) -1-octanone;
2, 2-dimethyl-1- (3-methyl-3- (cyclopentylmethyl) -5-bromoindolin-1-yl) -1-propanone;
1- (3-methyl-3- (cycloheptylmethyl) -5-bromoindolin-1-yl) -1-octanone;
1- (3-methyl-3- (cyclooctylmethyl) -5-bromoindolin-1-yl) -1-octanone;
1- (3- (cyclohexylmethyl) indolin-1-yl) -1-octanone;
1- (5-methyl-3- (cyclohexylmethyl) indolin-1-yl) -1-octanone;
1- (3- (cyclohexylmethyl) -5-bromoindolin-1-yl) -1-octanone.
CN201910136346.7A 2019-02-25 2019-02-25 Method for synthesizing 3-alkyl indoline by alkylation of non-activated olefin under catalysis of copper Active CN109912488B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910136346.7A CN109912488B (en) 2019-02-25 2019-02-25 Method for synthesizing 3-alkyl indoline by alkylation of non-activated olefin under catalysis of copper

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910136346.7A CN109912488B (en) 2019-02-25 2019-02-25 Method for synthesizing 3-alkyl indoline by alkylation of non-activated olefin under catalysis of copper

Publications (2)

Publication Number Publication Date
CN109912488A CN109912488A (en) 2019-06-21
CN109912488B true CN109912488B (en) 2022-05-10

Family

ID=66962206

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910136346.7A Active CN109912488B (en) 2019-02-25 2019-02-25 Method for synthesizing 3-alkyl indoline by alkylation of non-activated olefin under catalysis of copper

Country Status (1)

Country Link
CN (1) CN109912488B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114874119B (en) * 2022-03-06 2023-06-06 昆明学院 Method for synthesizing 3, 4-dialkylated-4-pyrroline-2-one derivative by photocatalysis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0987235A1 (en) * 1998-08-25 2000-03-22 MERCK PATENT GmbH Method for the conversion of arenes or alkenes with iodoalkenes, aryl iodides or arenediazonium salts
CN104557661A (en) * 2014-12-25 2015-04-29 湖南大学 Preparation method for synthesizing indoline through idodine catalysis of amide compound

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0987235A1 (en) * 1998-08-25 2000-03-22 MERCK PATENT GmbH Method for the conversion of arenes or alkenes with iodoalkenes, aryl iodides or arenediazonium salts
CN104557661A (en) * 2014-12-25 2015-04-29 湖南大学 Preparation method for synthesizing indoline through idodine catalysis of amide compound

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Copper-catalyzed alkylarylation of activated alkenes using isocyanides as the alkyl source: An efficient radical access to 3,3-dialkylated oxindoles;zhao yaping;《Chem.Commun.》;20161231;全文 *
Highly Regioselective Indoline Synthesis under Nickel/Photoredox Dual Catalysis;Sarah Z. Tasker et,al.;《J.Am.Chem.Soc》;20150721;全文 *
Microwave-Assisted Copper-Catalyzed Oxidative Cyclization of Acrylamides with Non-Activated Ketones;Yaping Zhao;《Chem.Eur.J.》;20161231;第22卷;第5878-5882页 *

Also Published As

Publication number Publication date
CN109912488A (en) 2019-06-21

Similar Documents

Publication Publication Date Title
Ju et al. Synthesis of oxindoles via visible light photoredox catalysis
Fang et al. Transition-metal-free radical fluoroalkylation of isocyanides for the synthesis of tri-/di-/monofluoromethylated phenanthridines
Chen et al. Eosin Y-catalyzed one-pot synthesis of spiro [4H-pyran-oxindole] under visible light irradiation
Cioc et al. Furoic acid and derivatives as atypical dienes in Diels–Alder reactions
CN108299296B (en) Preparation method of phenanthridine heterocyclic compound
Wang et al. Facile syntheses of 3-trifluoromethylthio substituted thioflavones and benzothiophenes via the radical cyclization
EP3778538A1 (en) Novel method for synthesizing deuterated amides and deuterated sulfonamides
Tang et al. DIAD as a promoter for cyanomethylation of alkenes by Cu catalysis
CN109912488B (en) Method for synthesizing 3-alkyl indoline by alkylation of non-activated olefin under catalysis of copper
Ma et al. Photoredox-catalyzed intermolecular azidosulfonylation of alkenes with DABCO·(SO 2) 2, trimethylsilyl azide and thianthrenium salts
Wang et al. Decatungstate as a direct hydrogen atom transfer photocatalyst for synthesis of trifluromethylthioesters from aldehydes
Ni et al. A convenient access to allylic triflones with allenes and triflyl chloride in the presence of (EtO) 2P (O) H
Tribak et al. Synthesis and reactivity of new heterocyclic systems derived from 5-chloro-1H-indole-2, 3-dione
CN110981676B (en) Method for preparing beta-ketosulfone compound through visible light mediated atoxic acid decarboxylation ketonization reaction
CN110330450B (en) Preparation method of asymmetric thiourea compound
CN109824573A (en) The method that N- allyl aniline cyanoalkyl is combined to cyanoalkyl indoline
CN105622464A (en) Method for preparing chiral hydrazine
Mohammed Khan et al. Ultrasound-Assisted, Convenient and Widely Applicable 1, 1'-Carbonyl-diimidazole-Mediated
Wu et al. Acid-mediated transformation of spirocyclopropyl oxetanes: a facile approach to spirocyclopropyl butenolides and γ-butyrolactones
Pandey et al. KOH-mediated intramolecular amidation and sulfenylation: A direct approach to access 3-(arylthio) imidazo [1, 2-a] pyridin-2-ols
Flekhter et al. Synthesis and Antiulcer Activity of Quinopimaric Acid Derivatives.
Sośnicki Michael addition of nitroalkanes to nonactivated α, β-unsaturated δ-thiolactams: reactivity, diastereoselectivity, and comparison to α, β-unsaturated δ-lactams
CN110590631B (en) Synthetic method of 2, 2-bis-sulfonyl-2H-aziridine
CN111018784B (en) Preparation method of benzoazepine compound
KR102548571B1 (en) Spiro[indoline-3,2'-piperidin] derivatives and method for producing the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant